https://www.selleckchem.com/pr....oducts/cilofexor-gs-
This study aimed to evaluate the crude incidence rates and relative risk of malignancy in Korean patients with SLE. We conducted a retrospective nationwide cohort study using databases from the National Health Insurance Service in Korea. All prevalent SLE patients aged over 19 were identified from January 2012 to December 2014 and observed until the diagnosis of malignancy, death, or end of the study, December 2015. The crude incidence rates (IRs) and standardised incidence ratios (SIRs) of overall and site-specific malignanci
Like
Comment
Share
